DAB2IP and esophageal squamous cell carcinoma: In this study, to determine whether abnormalities of DAB2IP were involved in the pathogenesis and chemoradiosensitivity of ESCC, we applied immunohistochemistry (IHC) analysis to examine the expression of DAB2IP in a cohort of biopsy specimens of primary ESCC patients treated with definitive CRT.